ACOTEC-B (06669) Schedules 26 March 2026 Board Meeting to Approve FY2025 Audited Results and Consider Final Dividend

Bulletin Express

Mar 16

Acotec Scientific Holdings Limited (stock code 06669, “ACOTEC-B”) has announced that its board of directors will convene on 26 March 2026. The agenda includes:

• Reviewing and approving the audited consolidated results of ACOTEC-B and its subsidiaries for the financial year ended 31 December 2025.

• Deliberating on the declaration and payment of a final dividend, if any, for the period under review.

The meeting will be chaired by Executive Director and Chief Executive Officer Ms. Jing Li, who also serves as Chairperson of the Board. The current board comprises one executive director, three non-executive directors, and three independent non-executive directors.

The company plans to release its audited annual results to the market following board approval on the meeting date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1197618855"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1197618855\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1197618855?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 16:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1197618855","market":"hk","top_or_hot":-1,"title":"ACOTEC-B (06669) Schedules 26 March 2026 Board Meeting to Approve FY2025 Audited Results and Consider Final Dividend","media":"Bulletin Express","content":"<p>Acotec Scientific Holdings Limited (stock code 06669, “ACOTEC-B”) has announced that its board of directors will convene on 26 March 2026. The agenda includes:</p>\n<p>• Reviewing and approving the audited consolidated results of ACOTEC-B and its subsidiaries for the financial year ended 31 December 2025.</p>\n<p>• Deliberating on the declaration and payment of a final dividend, if any, for the period under review.</p>\n<p>The meeting will be chaired by Executive Director and Chief Executive Officer Ms. Jing Li, who also serves as Chairperson of the Board. The current board comprises one executive director, three non-executive directors, and three independent non-executive directors.</p>\n<p>The company plans to release its audited annual results to the market following board approval on the meeting date.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ACOTEC-B (06669) Schedules 26 March 2026 Board Meeting to Approve FY2025 Audited Results and Consider Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nACOTEC-B (06669) Schedules 26 March 2026 Board Meeting to Approve FY2025 Audited Results and Consider Final Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-16 16:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Acotec Scientific Holdings Limited (stock code 06669, “ACOTEC-B”) has announced that its board of directors will convene on 26 March 2026. The agenda includes:</p>\n<p>• Reviewing and approving the audited consolidated results of ACOTEC-B and its subsidiaries for the financial year ended 31 December 2025.</p>\n<p>• Deliberating on the declaration and payment of a final dividend, if any, for the period under review.</p>\n<p>The meeting will be chaired by Executive Director and Chief Executive Officer Ms. Jing Li, who also serves as Chairperson of the Board. The current board comprises one executive director, three non-executive directors, and three independent non-executive directors.</p>\n<p>The company plans to release its audited annual results to the market following board approval on the meeting date.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06669","symbol_name":"先瑞达医疗-B","start_time":0,"source_url":"","article_id":"1197618855","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1197618855","pubTimestamp":1773650465,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Acotec Scientific Holdings Limited (stock code 06669, “ACOTEC-B”) has announced that its board of directors will convene on 26 March 2026. The agenda includes: • Reviewing and approving the audited...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06669":"先瑞达医疗-B"},"translate_title":"先瑞达-B(06669)定于2026年3月26日召开董事会批准2025财年经审核业绩并考虑末期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06669":1},"content_text":"Acotec Scientific Holdings Limited (stock code 06669, “ACOTEC-B”) has announced that its board of directors will convene on 26 March 2026. The agenda includes:\n• Reviewing and approving the audited consolidated results of ACOTEC-B and its subsidiaries for the financial year ended 31 December 2025.\n• Deliberating on the declaration and payment of a final dividend, if any, for the period under review.\nThe meeting will be chaired by Executive Director and Chief Executive Officer Ms. Jing Li, who also serves as Chairperson of the Board. The current board comprises one executive director, three non-executive directors, and three independent non-executive directors.\nThe company plans to release its audited annual results to the market following board approval on the meeting date.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}